1-19 of 19
Sort by
News

Biden Appoints ASH Member to National Cancer Advisory Board

Published: 2024
Abstract
November 2024
View News titled, Biden Appoints ASH Member to National Cancer Advisory Board
News

ASH Member Awarded HHS Exceptional Service Medallion

Published: 2024
Abstract
November 2024
View News titled, ASH Member Awarded HHS Exceptional Service Medallion
News

NAM Elects Two ASH Members

Published: 2024
Abstract
November 2024
View News titled, NAM Elects Two ASH Members
News

Medication for Newly Diagnosed MM Receives FDA Approval

Published: 2024
Abstract
November 2024
View News titled, Medication for Newly Diagnosed MM Receives FDA Approval
News

FDA Approves Hemophilia A, B Treatment

Published: 2024
Abstract
November 2024
View News titled, FDA Approves Hemophilia A, B Treatment
News

FDA Places Novavax Trial on Hold

Published: 2024
Abstract
November 2024
View News titled, FDA Places Novavax Trial on Hold
News

Bluebird Bio Medication Linked to Blood Cancers

Published: 2024
Abstract
November 2024
View News titled, Bluebird Bio Medication Linked to Blood Cancers
News

November 2024 Data Stream

Published: 2024
Abstract
November 2024
View News titled, November 2024 Data Stream
News

You Make the Call: How would you treat a patient with a history of bilateral PE and subsequent DVT?

Published: 2024
Abstract
November 2024
View News titled, You Make the Call: How would you treat a patient with a history of bilateral PE and subsequent DVT?
News

Building Critical Skills and Mentorship in Clinical Research: Insights from the ASH CRTI

Published: 2024
Abstract
November 2024
View News titled, Building Critical Skills and Mentorship in Clinical Research: Insights from the ASH CRTI
News

When Treatment Includes Substance Use Disorders

Leah Lawrence
Published: 2024
Abstract
November 2024 A patient’s substance use disorder can complicate treatment for a hematologic condition, but physicians must view the comorbidity as an opportunity to provide support.
View News titled, When Treatment Includes Substance Use Disorders
News

Genetics-Based Risk Model to Stratify Survival Outcomes of Patients With AML Treated With Venetoclax-Azacitidine

Anna Azvolinsky, PhD
Published: 2024
Abstract
November 2024
View News titled, Genetics-Based Risk Model to Stratify Survival Outcomes of Patients With AML Treated With Venetoclax-Azacitidine
News

How would you treat a patient with a history of bilateral PE and subsequent DVT?

Published: 2024
Abstract
November 2024
View News titled, How would you treat a patient with a history of bilateral PE and subsequent DVT?
News

Bridging the Divide: Global Equity in CAR T-Cell Therapy

Published: 2024
Abstract
November 2024
View News titled, Bridging the Divide: Global Equity in CAR T-Cell Therapy
News

A Network of Support: International Organizations Assist Doctors and Patients in War-Torn Countries

Jill Sederstrom
Published: 2024
Abstract
November 2024
View News titled, A Network of Support: International Organizations Assist Doctors and Patients in War-Torn Countries
News

Better Preventive Stroke Management Needed for SCD

Ruth Jessen Hickman, MD
Published: 2024
Abstract
November 2024
View News titled, Better Preventive Stroke Management Needed for SCD
News

Large Study Compares Serum Thrombopoietin Levels in Pediatric Patients With Acquired Aplastic Anemia, Immune Thrombocytopenia

Anna Azvolinsky, PhD
Published: 2024
Abstract
November 2024
View News titled, Large Study Compares Serum Thrombopoietin Levels in Pediatric Patients With Acquired Aplastic Anemia, Immune Thrombocytopenia
News

Etoposide Safe to Combine With Brentuximab Vedotin, Results in High CRR in Peripheral T-Cell Lymphoma

Katie Robinson
Published: 2024
Abstract
November 2024
View News titled, Etoposide Safe to Combine With Brentuximab Vedotin, Results in High CRR in Peripheral T-Cell Lymphoma
News

Early Aggressive Treatment of High-Risk Smoldering MM Results in High Rates of Sustained uMRD

Khylia Marshall
Published: 2024
Abstract
November 2024
View News titled, Early Aggressive Treatment of High-Risk Smoldering MM Results in High Rates of Sustained uMRD